Eastern Bank’s Vertex Pharmaceuticals VRTX Stock Holding History

Eastern Bank’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$152K	Sell	305 -57	-16%	-$25.3K	﹤0.01%	433
2026 Q1	$162K	Buy	362 +40	+12%	+$18.7K	﹤0.01%	396
2025 Q4	$146K	Sell	322 -316	-50%	-$136K	﹤0.01%	409
2025 Q3	$250K	Sell	638 -997	-61%	-$417K	﹤0.01%	334
2025 Q2	$728K	Buy	1,635 +25	+2%	+$11.5K	0.01%	211
2025 Q1	$781K	Sell	1,610 -10	-0.6%	-$4.66K	0.02%	222
2024 Q4	$652K	Sell	1,620 -111	-6%	-$51.5K	0.01%	248
2024 Q3	$805K	Buy	+1,731	New	+$832K	0.01%	239
2021 Q3	–	Sell	-3,300	Closed	-$665K	–	193
2021 Q2	$665K	Hold	3,300	–	–	0.03%	145
2021 Q1	$709K	Hold	3,300	–	–	0.04%	137
2020 Q4	$780K	Hold	3,300	–	–	0.04%	127
2020 Q3	$898K	Sell	3,300 -15	-0.5%	-$4.14K	0.06%	117
2020 Q2	$962K	Hold	3,315	–	–	0.06%	113
2020 Q1	$789K	Hold	3,315	–	–	0.06%	115
2019 Q4	$726K	Hold	3,315	–	–	0.04%	117
2019 Q3	$562K	Hold	3,315	–	–	0.04%	130
2019 Q2	$608K	Hold	3,315	–	–	0.04%	128
2019 Q1	$610K	Hold	3,315	–	–	0.04%	132
2018 Q4	$549K	Buy	3,315 +1,000	+43%	+$173K	0.04%	134
2018 Q3	$446K	Buy	+2,315	New	+$412K	0.03%	155

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

CTB

Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

GIA

Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return

IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

Eastern Bank's VRTX Position: Q2 2026 in Review

Eastern Bank reduced its Vertex Pharmaceuticals (VRTX) stake by 16% in Q2 2026, selling an estimated $25.3K and leaving 305 shares worth $152K. The position accounts for ﹤0.01% of the portfolio, ranked #433.

Eastern Bank first reported a position in VRTX in Q3 2018 and has held it in 20 quarters since. The position peaked at $962K in Q2 2020. 333 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Eastern Bank held 305 shares of Vertex Pharmaceuticals worth $152K as of Q2 2026.
Eastern Bank sold 57 Vertex Pharmaceuticals shares in Q2 2026, an estimated $25.3K.
Vertex Pharmaceuticals made up ﹤0.01% of Eastern Bank's portfolio in Q2 2026, its #433 holding.
Eastern Bank first reported a position in Vertex Pharmaceuticals in Q3 2018 and has held it in 20 quarters since.
Eastern Bank's Vertex Pharmaceuticals position peaked at $962K in Q2 2020.
333 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Eastern Bank's 13F filing for Q2 2026, filed 1 Jul 2026.